Thursday 16th December 2021 |
Text too small? |
NorthWest Healthcare Properties Management Limited (the Manager), as manager of Vital Healthcare Property Trust (Vital), expects Vital to record a property revaluation gain of approximately $140m for the six months ending 31 December 2021 with 80% of the portfolio (by value) independently valued. This preliminary draft revaluation gain represents a 5.3% increase since 30 June 2021 and reduces pro-forma LVR by 1.6%.
At 31 December 2021 Vital's property portfolio is anticipated to be valued at approximately $2.9b , 10% above 30 June 2021. The property portfolio weighted average capitalisation rate is approximately 4.66%, reflecting approximately 22 basis points of compression over the six-month period.
Vital's Fund Manager, Aaron Hockly, said:
" Investor appetite for quality Australian and New Zealand healthcare property remains strong demonstrated by several recent and anticipated transactions. Investors are particularly attracted to the sector's relatively low risk and low volatility."
The preliminary draft revaluation gain referred to above is subject to finalisation and audit and could be revised up or down. Final audited valuations will be confirmed when Vital's half year results are released on 24 February 2022.
FY22 market guidance remains at least 11.80 cpu in AFFO (2% above FY21) and 9.5 cpu in unitholder distributions (7% above FY21).
Please see the link below for details
Vital valuations announcement 1H FY22
Source: Vital Healthcare Property Trust
No comments yet
FPH launches F&P Nova™ Nasal mask in NZ and AU
Fonterra announces changes to management team
March 12th Morning Report
WHS FY25 Interim Results teleconference details
VGL - Odeon Cinemas Group signs for Vista Cloud
DGL - T&G appoints new Director
TEM - Transaction in Own Shares
Fonterra lifts FY25 earnings guidance
Fonterra releases divestment roadshow presentation
March 10th Morning Report